Delivery Order SPE2DB25D3017-SPE2DB25FVKAT
- Not listed
- The Defense Logistics Agency awarded a $19,989.93 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $11,893.32 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $48,177.56 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV infection, reflecting the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $29,406.51 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract has an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the critical pharmaceutical supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for $43,157.04 to supply Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV,...
- The Defense Logistics Agency awarded a delivery order valued at $8,740.92 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting...
- The Defense Logistics Agency awarded a $20,611.42 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by August 13, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Biktarvy is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $31,127.49 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $67,808.28 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Biktarvy is a prescription antiretroviral medication used in the treatment of HIV...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $15,248.99 and is scheduled for completion by August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKATDelivery Order
The Defense Logistics Agency awarded a $24,341.53 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV, indicating this delivery supports federal healthcare procurement for military and veteran populations. This delivery order represents a single task order executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems globally. The company's status as a major pharmaceutical distributor and established federal contractor demonstrates its capability to fulfill specialized medical procurement requirements through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 7/30/25 |